In this training, Dr. Jorge Mera discusses the epidemiology of HCV, how to recognize clinical manifestations, ways to implement screening & interpret diagnostic tests, and how to develop treatment &… […]
Keyword: cure
HCV 101: Screening, Treatment and Management | January 29, 2025
In this training, Dr. Jorge Mera discusses screening, treatment and management of patients with hepatitis C in primary care and provides an opportunity to become part of a learning community. […]
Read More… from HCV 101: Screening, Treatment and Management | January 29, 2025
Special ID Clinic and Hepatitis C Program at GIMC IHS | July 26, 2023
In this presentation, LT Jade-Ngoc Brookfield, shares the story of Gallup Indian Medical Center’s Special ID Clinic Hepatitis C program, how collaborative practice can improve patient care, their success’, challenges… […]
Read More… from Special ID Clinic and Hepatitis C Program at GIMC IHS | July 26, 2023
Substance Use and Injecting Behaviors During and After Hepatitis C Treatment Among Persons Who Inject Drugs | March 22, 2023
In this presentation, Kimberly Page, PhD, MPH, Professor of Epidemiology at The University of New Mexico, describes injection practices among people who inject drugs (PWID) before, during, and after HCV… […]
HCV Screening, Management and Treatment | October 26, 2022
In this presentation, Dr. Brad Moran, PharmD, and Dr. Paulina Deming, PharmD provide an overview of HCV Elimination with a focus on treatments, screening, prevention, and provider resources. Dr. Moran… […]
Read More… from HCV Screening, Management and Treatment | October 26, 2022
Ending the Epidemics in Indian Country: HCV | May 10th 2022
In this series of presentations we hear from Dr. Jorge Mera on HCV Elimination with a focus on treatments, screening, prevention, and provider resources. Next, CDR Dawn Benth, PHN; LCDR… […]
Read More… from Ending the Epidemics in Indian Country: HCV | May 10th 2022
Residual Risk for HCC in Patients After HCV SVR | February 23, 2022
In this presentation, Dr. Raymond Chung, 2021 AASLD President and Director of Hepatology and the Liver Center at Massachusetts General Hospital, discusses the residual risk for hepatocellular carcinoma in patients after… […]
Read More… from Residual Risk for HCC in Patients After HCV SVR | February 23, 2022











































